Trial Profile
A retrospective case series study of as needed schedule of dexamethasone intravitreal implant in patients with macular edema due to branch retinal vein occlusion (BRVO) or central retinal vein occlusion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2018
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Branch retinal vein occlusion; Central retinal vein occlusion; Retinal oedema
- Focus Therapeutic Use
- 03 Apr 2018 New trial record